Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 36, Issue 1, Pages 270-285
Publisher
Informa UK Limited
Online
2020-12-17
DOI
10.1080/14756366.2020.1862101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
- (2020) Heba T. Abdel‐Mohsen et al. ARCHIV DER PHARMAZIE
- Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents
- (2020) Heba Abdelrasheed Allam et al. BIOORGANIC CHEMISTRY
- Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights
- (2020) Mohammad M. Al-Sanea et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- (2020) Lei Ding et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors
- (2020) Tarfah Al-Warhi et al. MOLECULES
- Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer
- (2020) Wagdy M. Eldehna et al. ACS Medicinal Chemistry Letters
- Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
- (2020) Przemysław Duda et al. Cells
- Structure–activity relationship studies of indolin‐2‐one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents
- (2020) Mozhdeh Yousefian et al. ARCHIV DER PHARMAZIE
- New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies
- (2019) Somaia S. Abd El-Karim et al. BIOORGANIC CHEMISTRY
- Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents
- (2019) Wagdy M. Eldehna et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review
- (2019) M. Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors
- (2019) Natalia A. Lozinskaya et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors
- (2019) Ahmed M. El Kerdawy et al. JOURNAL OF MOLECULAR MODELING
- Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
- (2019) Souad A. Elmetwally et al. BIOORGANIC CHEMISTRY
- Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
- (2019) Hazem A. Mahdy et al. BIOORGANIC CHEMISTRY
- Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors
- (2019) Heba T. Abdel-Mohsen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4- d ]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors
- (2018) Srinivasulu Cherukupalli et al. BIOORGANIC CHEMISTRY
- Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies
- (2018) Ahmed Sabt et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation
- (2018) Wagdy M. Eldehna et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers
- (2018) Tahir Ali Chohan et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
- (2018) Mahmoud F. Abo-Ashour et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Analysis of the role of GSK3 in the mitotic checkpoint
- (2018) M. S. Rashid et al. Scientific Reports
- Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and molecular docking
- (2018) Liliana Pacureanu et al. STRUCTURAL CHEMISTRY
- Glycogen synthase kinase-3 inhibition in glioblastoma multiforme cells induces apoptosis, cell cycle arrest and changing biomolecular structure
- (2018) Eda Acikgoz et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis
- (2018) Babita Aneja et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides
- (2018) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition mechanism of CDK-2 and GSK-3β by a sulfamoylphenyl derivative of indoline—a molecular dynamics study
- (2017) Przemysław Czeleń JOURNAL OF MOLECULAR MODELING
- Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling
- (2017) Hatem Abdel-Aziz et al. Drug Design Development and Therapy
- Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
- (2017) Angela Alexander et al. Oncotarget
- New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres
- (2017) Mohamed I. Attia et al. PLoS One
- GSK-3 inhibition overcomes chemoresistance in human breast cancer
- (2016) Andrey Ugolkov et al. CANCER LETTERS
- Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors
- (2016) Aziz Ouach et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran–pyrazole derivatives as anticancer agents
- (2015) Somaia S. Abd El-Karim et al. BIOORGANIC CHEMISTRY
- Multi-Kinase Inhibitors
- (2015) Laura Garuti et al. CURRENT MEDICINAL CHEMISTRY
- Advances in tetrahydropyrido[1,2- a ]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors
- (2015) Rajâa Boulahjar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Bioactive Benzofuran derivatives: A review
- (2015) Hena Khanam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity
- (2015) Minhajul Arfeen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Expression and prognostic significance of VEGFR-2 in breast cancer
- (2015) Ji-Dong Yan et al. PATHOLOGY RESEARCH AND PRACTICE
- Endpoint of Cancer Treatment: Targeted Therapies
- (2014) Mehmet Topcul et al. Asian Pacific Journal of Cancer Prevention
- CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro
- (2014) Xiangming He et al. Cancer Cell International
- Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle
- (2014) Vanessa Oakes et al. CELL CYCLE
- Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents
- (2014) Tahir Chohan et al. CURRENT MEDICINAL CHEMISTRY
- Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia
- (2014) Ajit Dhananjay Jagtap et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors
- (2014) Ping Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents
- (2014) Haytham E. Dweedar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Bioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor
- (2014) Hsiao-Chun Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Benzofuran derivatives as a novel class of inhibitors of mTOR signaling
- (2014) Christophe Salomé et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Benzofuran derivatives as anticancer inhibitors of mTOR signaling
- (2014) Christophe Salomé et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure–activity relationship analysis
- (2013) Ye Zhong et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis, in vitro and in vivo antitumor activity of symmetrical bis-Schiff base derivatives of isatin
- (2013) Chengyuan Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents
- (2013) Radoslaw Laufer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
- (2012) K. Vine et al. Anti-Cancer Agents in Medicinal Chemistry
- GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients
- (2012) Mary Anne Quintayo et al. BREAST CANCER RESEARCH AND TREATMENT
- Novel Tetrahydropyrido[1,2-a]isoindolone Derivatives (Valmerins): Potent Cyclin-Dependent Kinase/Glycogen Synthase Kinase 3 Inhibitors with Antiproliferative Activities and Antitumor Effects in Human Tumor Xenografts
- (2012) Rajâa Boulahjar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways
- (2012) D. Horiuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors
- (2011) Yibin Xiang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines
- (2011) Anne Cooley et al. CELL CYCLE
- Physiological Relevance of Cell Cycle Kinases
- (2011) Marcos Malumbres PHYSIOLOGICAL REVIEWS
- Vascular endothelial growth factor receptor-2 in breast cancer
- (2010) Shanchun Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells
- (2010) Józefa Węsierska-Gądek et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Hierarchical Phosphorylation Cascade That Regulates the Timing of PERIOD Nuclear Entry Reveals Novel Roles for Proline-Directed Kinases and GSK-3 /SGG in Circadian Clocks
- (2010) H. W. Ko et al. JOURNAL OF NEUROSCIENCE
- Targeted cancer therapies
- (2010) Saurabh Aggarwal NATURE REVIEWS DRUG DISCOVERY
- Efficient Synthesis of a Benzo[b]furan Building Block
- (2010) Jaekyoo Lee et al. SYNTHETIC COMMUNICATIONS
- Recent developments in cyclin-dependent kinase biochemical and structural studies
- (2009) Aude Echalier et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
- (2009) N Johnson et al. BRITISH JOURNAL OF CANCER
- The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
- (2009) S. Ali et al. CANCER RESEARCH
- From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors That Suppress Proliferation and Survival of Pancreatic Cancer Cells
- (2009) Irina N. Gaisina et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cell cycle kinases as therapeutic targets for cancer
- (2009) Silvia Lapenna et al. NATURE REVIEWS DRUG DISCOVERY
- Recent Advances in the Development of Multi-Kinase Inhibitors
- (2008) Martin Krug et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search